Events
FDA approves imlunestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
- ASTRO 2025: Health-related quality of life analysis shows benefit in both proton and photon radiation options in breast cancer patients
- NATALEE 4-year data: Ribociclib extends recurrence-free survival in early breast cancer
- New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers
The OJC Episode 48: Procrastination and P Values
The Oncology Journal Club Episode 48: Procrastination and P Values Welcome to another entertaining and informative episode. We’re all about…
How ‘chameleon cancers’ can change their colours to survive treatment
Some leukaemia evade treatment by changing their appearance and identity through changing the read-out of their DNA, a new study…










